| iPSC-Derived Astrocytes | |
|---|---|
| Lineage | Stem Cell > iPSC > Astrocyte |
| Markers | GFAP, S100β, ALDH1L1, AQP4, EAAT1, EAAT2 |
| Brain Regions | In Vitro |
| Disease Relevance | Alzheimer's Disease, Parkinson's Disease, ALS, Astrocytosis |
| Protocol | Directed Differentiation (30-90 days) |
iPSC-Derived Astrocytes
Introduction
Ipsc Derived Astrocytes is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
iPSC-Derived Astrocytes are specialized glial cells generated from induced pluripotent stem cells (iPSCs) through directed differentiation protocols that recapitulate astrogliogenesis during central nervous system development.22011 - Directed differentiation of functional astrocytes from human pluripotent stem cellsOpen reference These cells express characteristic astrocytic markers including GFAP (glial fibrillary acidic protein), S100β, ALDH1L1, and the water channel AQP4, defining their identity as authentic astrocytes.32017 - Human iPSC-derived astrocytes: disease modeling and therapeutic applicationsOpen reference
iPSC-derived astrocytes provide physiologically relevant in vitro models for studying neurodevelopment, neuroinflammation, and neurodegenerative diseases.42023 - Astrocyte disease modeling with iPSCsOpen reference These cells are particularly valuable for modeling Alzheimer’s disease, Parkinson’s disease, and ALS, where astrocyte dysfunction plays a critical role in disease pathogenesis.52024 - iPSC astrocytes in neurodegeneration researchOpen reference
Differentiation Protocol
The generation of astrocytes from iPSCs typically follows a directed differentiation approach:
Stage 1: Neural Progenitor Generation (Days 0-14)
-
Dual SMAD inhibition for neural induction
-
Formation of neural rosettes
-
Pax6, Sox2 expression
Stage 2: Astrocyte Progenitor Specification (Days 14-30)
-
Exposure to CNTF, BMP, and LIF
-
GFAP expression initiation
-
Astrocyte progenitor proliferation
Stage 3: Astrocyte Maturation (Days 30-90)
-
Acquisition of mature astrocyte markers
-
S100β, ALDH1L1 expression
-
Functional glutamate uptake (EAAT1/2)
-
Potassium buffering capability
Astrocyte Subtypes
Proliferative Astrocytes
-
Express GFAP, nestin
-
Reactive astrogliosis
-
Injury response
Mature Astrocytes
-
S100β+, ALDH1L1+
-
Normal CNS function
-
Homeostatic support
Disease-Associated Astrocytes (DAA)
-
Emerge in disease conditions
-
Inflammatory phenotype
-
Neurotoxic or neuroprotective
Marker Expression
| Marker | Type | Function |
|---|---|---|
| GFAP | Intermediate Filament | Astrocyte identity, reactivity |
| S100β | Calcium-binding Protein | Astrocyte maturation |
| ALDH1L1 | Enzyme | Folate metabolism |
| AQP4 | Water Channel | Water homeostasis |
| EAAT1 (GLAST) | Transporter | Glutamate uptake |
| EAAT2 (GLT1) | Transporter | Glutamate uptake |
| Connexin 43 | Gap Junction | Astrocyte coupling |
Functional Properties
Homeostatic Functions
-
Ion homeostasis: Potassium buffering via Kir4.1
-
Water balance: AQP4-mediated water flux
-
pH regulation: Carbonic anhydrase activity
-
Metabolic support: Lactate shuttling to neurons
Neurotransmitter Recycling
-
Glutamate uptake: EAAT1/2-mediated clearance
-
GABA recycling: Polyamine metabolism
-
Monoamine metabolism: MAO activity
Synaptic Support
-
Synaptogenesis: D-serine, thrombospondin release
-
Synapse pruning: Complement-mediated elimination
-
Neurotransmitter precursors: Glutamine production
Disease Modeling Applications
Alzheimer’s Disease
iPSC-derived astrocytes from AD patients exhibit:
-
Aβ clearance defects: Reduced LRP1-mediated uptake12015 - Alzheimer's disease astrocyte phenotypesOpen reference
-
Inflammatory response: Increased IL-6, TNF-α secretion
-
Metabolic dysfunction: Altered glycolysis
-
Reactive gliosis: GFAP upregulation
Parkinson’s Disease
-
α-Synuclein uptake: May propagate pathology
-
Inflammatory activation: Cytokine release
-
Metabolic support deficits: Reduced lactate production
Amyotrophic Lateral Sclerosis (ALS)
-
EAAT2 dysfunction: Reduced glutamate clearance
-
Inflammatory phenotype: Pro-inflammatory cytokine release
-
Support deficits: Impaired neuronal support
Co-Culture Applications
Neuron-Astrocyte Co-Cultures
-
Improved neuronal maturation
-
Synapse formation enhancement
-
Disease mechanism studies
Triple Cultures
-
Neurons, astrocytes, microglia
-
More physiological modeling
-
Neuroimmune interactions
Comparative Analysis
| Differentiation Method | Maturation Time | Marker Expression | Function |
|---|---|---|---|
| Spontaneous differentiation | 60-90 days | Variable | Research |
| CNTF/BMP patterning | 30-60 days | Robust | Disease modeling |
| Defined medium | 40-70 days | Moderate | Standardization |
Therapeutic Applications
Drug Screening
-
Astrocyte-targeted therapies
-
Anti-inflammatory compounds
-
Metabolic modulators
Cell Therapy
-
Astrocyte transplantation
-
Supportive cell therapy
-
Gene therapy vectors
See Also
-
[Amyotrophic Lateral Sclerosis (ALS)amyotrophic-lateral-sclerosis-als)
-
[Disease-Associated Astrocytes (DAA)disease-associated-astrocytes-daa)
-
[GFAP](/diseases/disease-associated-astrocytes-daa](/content/diseases)
Pathway Diagram
graph TD
ASTROCYTES["ASTROCYTES"] -->|"regulates"| Als["Als"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| AKT["AKT"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| Multiple_Sclerosis["Multiple Sclerosis"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| Autoimmune["Autoimmune"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| Dementia["Dementia"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| Alzheimer["Alzheimer"]
ASTROCYTES["ASTROCYTES"] -->|"regulates"| Inflammation["Inflammation"]
ASTROCYTES["ASTROCYTES"] -->|"regulates"| Neuroinflammation["Neuroinflammation"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| Als["Als"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| Complement["Complement"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| Inflammation["Inflammation"]
style ASTROCYTES fill:#4a1a6b,stroke:#333,color:#e0e0e0
style Als fill:#ef5350,stroke:#333,color:#e0e0e0
style AKT fill:#4a1a6b,stroke:#333,color:#e0e0e0
style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#e0e0e0
style Autoimmune fill:#ef5350,stroke:#333,color:#e0e0e0
style Dementia fill:#ef5350,stroke:#333,color:#e0e0e0
style Alzheimer fill:#ef5350,stroke:#333,color:#e0e0e0
style Inflammation fill:#ef5350,stroke:#333,color:#e0e0e0
style Neuroinflammation fill:#ef5350,stroke:#333,color:#e0e0e0
style Complement fill:#1b5e20,stroke:#333,color:#e0e0e0
style NEUROINFLAMMATION fill:#4a1a6b,stroke:#333,color:#e0e0e0Pathway Diagram
The following diagram shows the key molecular relationships involving iPSC-Derived Astrocytes discovered through SciDEX knowledge graph analysis:
graph TD
FRONTOTEMPORAL_DEMENTIA["FRONTOTEMPORAL DEMENTIA"] -->|"activates"| IPSC["IPSC"]
FIBROBLASTS["FIBROBLASTS"] -->|"activates"| IPSC["IPSC"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| IPSC["IPSC"]
ALS["ALS"] -->|"activates"| IPSC["IPSC"]
ALS["ALS"] -->|"regulates"| IPSC["IPSC"]
CORTEX["CORTEX"] -->|"activates"| IPSC["IPSC"]
AGING["AGING"] -->|"associated with"| IPSC["IPSC"]
NEURONS["NEURONS"] -->|"activates"| IPSC["IPSC"]
NF__B["NF-κB"] -->|"activates"| IPSC["IPSC"]
MOTOR_NEURONS["MOTOR NEURONS"] -->|"activates"| IPSC["IPSC"]
Stem_Cell["Stem Cell"] -->|"activates"| IPSC["IPSC"]
AUTOPHAGY["AUTOPHAGY"] -->|"activates"| IPSC["IPSC"]
Tdp_43["Tdp-43"] -->|"activates"| IPSC["IPSC"]
AGING["AGING"] -->|"activates"| IPSC["IPSC"]
STING["STING"] -->|"activates"| IPSC["IPSC"]
style FRONTOTEMPORAL_DEMENTIA fill:#ef5350,stroke:#333,color:#000
style IPSC fill:#4fc3f7,stroke:#333,color:#000
style FIBROBLASTS fill:#80deea,stroke:#333,color:#000
style ASTROCYTES fill:#80deea,stroke:#333,color:#000
style ALS fill:#ef5350,stroke:#333,color:#000
style CORTEX fill:#b39ddb,stroke:#333,color:#000
style AGING fill:#4fc3f7,stroke:#333,color:#000
style NEURONS fill:#4fc3f7,stroke:#333,color:#000
style NF__B fill:#4fc3f7,stroke:#333,color:#000
style MOTOR_NEURONS fill:#4fc3f7,stroke:#333,color:#000
style Stem_Cell fill:#80deea,stroke:#333,color:#000
style AUTOPHAGY fill:#4fc3f7,stroke:#333,color:#000
style Tdp_43 fill:#81c784,stroke:#333,color:#000
style STING fill:#ce93d8,stroke:#333,color:#000References
- 2015 - Alzheimer's disease astrocyte phenotypes
- 2011 - Directed differentiation of functional astrocytes from human pluripotent stem cells
- 2017 - Human iPSC-derived astrocytes: disease modeling and therapeutic applications
- 2023 - Astrocyte disease modeling with iPSCs
- 2024 - iPSC astrocytes in neurodegeneration research
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.